Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 4/20 | 0.36 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | RARB | P10826 | 4/20 | 0.36 |
| ▸ | RARA | P10276 | 1/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16807672 | 0.91 | SPHK2 (0.41) | PPARGCNR1CNR2GPR55 | |
| SCHEMBL16807701 | 0.88 | HSD17B10 (0.42) | PTGS2PPARGRARBRARARARG | |
| SCHEMBL16024631 | 0.86 | HSD11B1 (0.40) | CNR1CNR2RARBRARARARG | |
| SCHEMBL16024627 | 0.86 | HSD11B1 (0.40) | CNR1CNR2RARBRARARARG | |
| SCHEMBL16807599 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 | |
| SCHEMBL16807660 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 | |
| SCHEMBL16024602 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 | |
| SCHEMBL16807657 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 | |
| SCHEMBL16807658 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 | |
| SCHEMBL16807615 | 0.86 | ESR1 (0.41) | PTGS2HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9586972-B2 | Organic thin film transistor, organic semiconductor thin film, and organic semiconductor material | FUJIFILM CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20150166560-A1 | ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL | FUJIFILM CORPORATION (JP) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166560-A1 | ORGANIC THIN FILM TRANSISTOR, ORGANIC SEMICONDUCTOR THIN FILM, AND ORGANIC SEMICONDUCTOR MATERIAL | OR10J3, SLC19A1, SLCO2A1 | GPR84 3461/4885PTGS2 3612/4885PPARG 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.